Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells

ABSTRACT: Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells

PROVIDER: PRJNA750676 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Screening and verification of differentially expressed long non-coding RNAs in the peripheral blood of patients with asthma

Project description:Purpose: The goals of this study are to explore the differentially expressed long non-coding RNAs in the peripheral blood of patients with asthma. Methods: lncRNA and mRNA profiles of peripheral blood (human) were generated by deep sequencing. Results: There were 1137 differentially expressed lncRNAs in the asthma patients compared to in the healthy controls, of which 485 were upregulated and 652 were downregulated.

2022-01-30 | GSE195599 | GEO

Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity

Project description:Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity

| PRJNA395745 | ENA

Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells

Project description:Daidzein has been found to significantly inhibit the proliferation of lung cancer cells, while its potential molecular mechanisms remain unclear. To determine the molecular mechanism of daidzein on lung cancer cells, the Capital Bio Technology Human long non-coding (lnc)RNA Array v4, 4x180K chip was used to detect the gene expression profiles of 40,000 lncRNAs and 34,000 mRNAs in a human cancer cell line. Reverse transcription-quantitative (RT-q) PCR analysis was performed to detect the expression levels of target lncRNA and mRNAs in the H1299 cells treated with and without daidzein, using the lncRNA and mRNA gene chip. Bioinformatics analysis was performed to determine the differentially expressed genes from the results of the chip assays. There were 119 and 40 differentially expressed lncRNAs and mRNAs, respectively, that had a 2-fold change in expression level. A total of eight lncRNAs were upregulated in the H1299 lung cancer cells, while 111 lncRNAs were downregulated. Furthermore, five mRNAs were upregulated, and 35 mRNAs were downregulated. A total of six differentially expressed lncRNAs (ENST00000608897.1, ENST00000444196.1, ENST00000608741.1, XR_242163.1, ENST00000505196.1 and ENST00000498032.1) were randomly selected to validate the microarray data, which were consistent with the RT-qPCR analysis results. Differentially expressed mRNAs were enriched in important Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways. Taken together, the results of the present study demonstrated that daidzein affected the expression level of lncRNAs in lung cancer cells, suggesting that daidzein may have potential effects on lung cancer cells.

2021-08-05 | GSE181093 | GEO

Comprehensive identification of long non-coding RNAs expressed during zebrafish embryogenesis

Project description:This SuperSeries is composed of the following subset Series: GSE32898: Comprehensive identification of long non-coding RNAs expressed during zebrafish embryogenesis [RNA_seq] GSE32899: Comprehensive identification of long non-coding RNAs expressed during zebrafish embryogenesis [ChIP_Seq] Refer to individual Series

2011-11-17 | E-GEOD-32900 | biostudies-arrayexpress

Identification of differentially expressed long non-coding RNAs in bladder cancer

Project description:As various data suggest that lncRNAs are important in human cancer, we hypothesized that they play a role in urothelial carcinogenesis. To test this hypothesis we analysed 83 normal and malignant urothelial samples using NCodeM-bM-^DM-" Human Non-coding RNA Microarrays for differentially expressed lncRNAs with potential regulatory functions in urothelial cell cancer (UCC). We identified global changes in lncRNA expression that reflect the disease phenotype. We then performed explorative analysis (siRNA gene knock-down and loss-of-function studies) of selected species and identified those with potential prognostic roles. Quantitative real-time PCR was used to validate the microarray findings. Total RNA was extracted from urothelial samples from 57 patients with UCC (23 low-grade NMI, 14 high-grade NMI and 20 invasive tumours) and from 26 disease free controls.

2014-02-28 | E-GEOD-55433 | biostudies-arrayexpress

Transcriptome-Wide Identification of Differentially Expressed Genes and Long Non-coding RNAs in Nitroglycerin Tolerant Rat Aorta

Project description:Transcriptome-Wide Identification of Differentially Expressed Genes and Long Non-coding RNAs in Nitroglycerin Tolerant Rat Aorta

| PRJNA499077 | ENA

The differentially expressed circular and long non-coding RNAs in the prefrontal cortex of Nrf2-knockout mice

Project description:The differentially expressed circular and long non-coding RNAs in the prefrontal cortex of Nrf2-knockout mice

| PRJNA681513 | ENA

identification of differentially expressed Long Non-coding RNA profiles in advanced gastric cancer

Project description:Long non-coding RNAs (lncRNAs) may contribute to tumorigenesis and cancer progression by regulating the gene in various cancers, including advanced gastric cancer (AGC). To investigate differentially expressed lncRNAs in AGC, we use whole transcriptome sequencing in 3 pairs of human gastric adenocarcinoma and the corresponding normal tissues.

2023-08-10 | GSE210909 | GEO

Identification of differentially expressed long non-coding RNAs in bladder cancer

Project description:As various data suggest that lncRNAs are important in human cancer, we hypothesized that they play a role in urothelial carcinogenesis. To test this hypothesis we analysed 83 normal and malignant urothelial samples using NCode™ Human Non-coding RNA Microarrays for differentially expressed lncRNAs with potential regulatory functions in urothelial cell cancer (UCC). We identified global changes in lncRNA expression that reflect the disease phenotype. We then performed explorative analysis (siRNA gene knock-down and loss-of-function studies) of selected species and identified those with potential prognostic roles. Quantitative real-time PCR was used to validate the microarray findings.

2014-02-28 | GSE55433 | GEO